You are viewing a historical snapshot of United States (NYSE / Nasdaq). These figures are a preview to show what TradeTidings covers. Live, continuously updated United States sentiment and stock impact is a Pro feature.
Get live United States data with ProZoetis (ZTS)
4 stories published on ZTS since July 2026. See all coverage.
News sentiment trend
Counts of positive, neutral, and negative news items over the last 90 days. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Sentiment timeline
How news sentiment on Zoetis (ZTS) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
Why this reading
The recent items weighing most on this reading, by direction and influence.
Zoetis Stock: ZTS Launches Lenivia in Canada and the European Union
Direct news · Medium influence · Long term
Zoetis Stock: ZTS to Acquire Veterinary Imaging Firm VitalRADS
Direct news · Low influence · Long term
Zoetis Wins EU Approval for New Poultry Vaccine Poulvac Procerta HVT ND
Direct news · Low influence · Long term
Zoetis-Neogen Genomics Deal Faces Antitrust Scrutiny in New Zealand
Direct news · Low influence · Short term
Direct news
The most recent stories naming ZTS directly, across all of our coverage.
Zoetis Stock: ZTS Launches Lenivia in Canada and the European Union
Zoetis Stock: ZTS to Acquire Veterinary Imaging Firm VitalRADS
Zoetis-Neogen Genomics Deal Faces Antitrust Scrutiny in New Zealand
Zoetis Wins EU Approval for New Poultry Vaccine Poulvac Procerta HVT ND
Indirect drivers in the news
Macro, commodity, FX and regulatory forces that have moved ZTS, with the stories behind each.
No indirect-driver news for ZTS in our coverage yet.
Also monitored for ZTS (no news in our coverage yet): FDA approvals & trial outcomes, Drug pricing / FDA / IRA.
See the full picture
Sign up free to track ZTS, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track ZTS for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.